Look for any podcast host, guest or anyone
Showing episodes and shows of

Grunenthal

Shows

History and HearsayHistory and HearsayPoisoned Before Birth: The Horror Behind ThalidomidePoisoned Before Birth: The Horror Behind ThalidomideThis episode uncovers the chilling story of thalidomide — a drug that caused thousands of babies to be born with severe birth defects across the world.Timestamps: 0:00 - Intro 1:39 - Development of Thalidomide 8:36 - Medical Community Concerns10:40 - History of Grünenthal16:12 - Experimenting on Children   17:13 - Birth Defects20:19 - How 1 Woman saved America25:10 - Canada27:20 - Thalidomide finally removed?31:28 - Why was Thalidomide causing this 33:43 - After Effects36:14 -  Family reactions46:02 - Criminal Charges50:58 - Civil Court...2025-04-221h 05Indústria do FuturoIndústria do FuturoComo o IBP transforma previsibilidade em estratégia? O impacto no Supply ChainO que fazer quando o S&OP tradicional já não é suficiente para lidar com a complexidade atual do mercado? A previsibilidade de demanda continua sendo um desafio? E como transformar isso em vantagem competitiva?Neste episódio do Indústria do Futuro, recebemos Nelson Andric, Demand Planning and IBP Manager na Grünenthal Brasil, para uma conversa profunda sobre como o IBP (Integrated Business Planning) está revolucionando o planejamento na cadeia de suprimentos — indo muito além da operação e conectando de forma estratégica áreas como finanças, marketing e comercial.💥 Se você atua com PCP, plane...2025-04-151h 03PEP Talks ISPEPPEP Talks ISPEPPersuasive Petersen: How to make a lasting impact for patients at every stage of product developmentEmma hosts another edition of PEP Talks, featuring Dr. Gudula Peterson, the global patient engagement lead at Grunenthal. Gudula shares her extensive experience in the pharmaceutical industry, highlighting her journey from compliance to patient engagement. She discusses the evolution of patient involvement in clinical trials, emphasizing the importance of integrating patient perspectives early in the process. Gudula also reflects on her roles at Grunenthal, including her work in governmental affairs and patient centricity, and the impact of collaborative projects like the Societal Impact of Pain platform. She underscores the need for structured patient...2025-02-1720 minNC Podcast - Nutrizione ClinicaNC Podcast - Nutrizione Clinica#131: Obesità sarcopenica con la dott.ssa ParascandoloOggi parleremo obesità sarcopenica e asse intestino cervello con la dott.ssa Parascandolo Infografica puntata 131 Clinical definition of sarcopenia, Valter Santilli et al. - Clin Cases Miner Bone Metab. 2014 Sep The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia, Ben Kirk et al. - Age Ageing. 2024 Mar 22;53(3) Sarcopenia definition, diagnosis and treatment: consensus is growing, Avan Aihie Sayer et al. Age Ageing. 2022. Vivere senza dolore. Il significato sociale del dolore e le aspettative di soluzioni efficaci – 1° Rapporto Censis – Grunenthal. 2023 Role of Nutrition in the Management of Patients with Chronic Musculoskeletal Pain, Arturo Cuomo, Ileana...2025-02-0207 minHealthcare Changers PodcastHealthcare Changers Podcast#59: Robert Sunjic, Grünenthal [>] DACH-Cluster: Wie klappt das?Drei Länder, eine Vision – zahlreiche Herausforderungen: In Episode 59 des Healthcare Changers Podcasts nehmen wir Sie mit auf eine spannende Reise durch die DACH-Region (Deutschland, Österreich, Schweiz) und zeigen, wie die Pharmaindustrie Synergien über Grenzen hinweg schafft. Dazu spricht Gastgeber Dominik Flener mit Robert Sunjic, Countrycluster-Head DACH der Grünenthal-Gruppe, über die Kunst, ein Cluster zu führen, das kulturell, strukturell und wirtschaftlich so unterschiedlich ist – und dennoch zusammenwächst.Robert Sunjic teilt seinen Karriereweg, der ihn von einer Tätigkeit im Außendienst über leitende Positionen in Vertrieb und Marketing bis hin zur Führung eines ganzen Clusters...2025-01-231h 00Digital Transformation SeriesDigital Transformation SeriesMehrnaz Campbell in conversation with Carolina Quezada Correa from GrünenthalCarolina is known for her passion, energy, dedication, commitment, and her strong ability to build consensus. With over 10 years of experience in the pharmaceutical industry and a background in public relations, marketing, and communications. She later specialised in digital marketing and transformation, taking on key roles at Pfizer and Grünenthal. 2025-01-081h 03AnesthesiaExam PodcastAnesthesiaExam PodcastEvidence-Based Pain Medicine with Guilherme Ferreira Dos Santos, MD of Barcelona  Episode Title: Evidence-Based Regenerative Pain Medicine with Guilherme Ferreira Dos Santos, MD CIPS Host: David Rosenblum   Guest: Guilherme Ferreira Dos Santos, MD CIPS Episode Overview: In this insightful episode of the PainExam Podcast, Dr. David Rosenblum sits down with Dr. Guilherme Ferreira Dos Santos, a distinguished expert in pain medicine who is well known for his research, educational endeavors and expertise in Regenerative Pain Medicine and Ultrasound-Guided interventions. Together, they delve into the evolving landscape of regenerative pain medicine, focusing on evidence-based practices and the standardization of Platelet-Rich Plasma (PRP) quality.    2025-01-0233 minThe PMRExam PodcastThe PMRExam PodcastAn Interview with Guilherme Ferreira Dos Santos, MD CIPS. Regenerative Pain Medicine and more!  Episode Title: Evidence-Based Regenerative Pain Medicine with Guilherme Ferreira Dos Santos, MD CIPS Host: David Rosenblum   Guest: Guilherme Ferreira Dos Santos, MD CIPS Episode Overview: In this insightful episode of the PainExam Podcast, Dr. David Rosenblum sits down with Dr. Guilherme Ferreira Dos Santos, a distinguished expert in pain medicine who is well known for his research, educational endeavors and expertise in Regenerative Pain Medicine and Ultrasound-Guided interventions. Together, they delve into the evolving landscape of regenerative pain medicine, focusing on evidence-based practices and the standardization of Platelet-Rich Plasma (PRP) quality.    2025-01-0233 minPainExam PodcastPainExam PodcastEvidence-Based Regenerative Pain Medicine with Guilherme Ferreira Dos Santos, MD CIPS  Episode Title: Evidence-Based Regenerative Pain Medicine with Guilherme Ferreira Dos Santos, MD CIPS Host: David Rosenblum   Guest: Guilherme Ferreira Dos Santos, MD CIPS Episode Overview: In this insightful episode of the PainExam Podcast, Dr. David Rosenblum sits down with Dr. Guilherme Ferreira Dos Santos, a distinguished expert in pain medicine who is well known for his research, educational endeavors and expertise in Regenerative Pain Medicine and Ultrasound-Guided interventions. Together, they delve into the evolving landscape of regenerative pain medicine, focusing on evidence-based practices and the standardization of Platelet-Rich Plasma (PRP) quality.    2025-01-0233 minConexión Salud con Carles AguilarConexión Salud con Carles Aguilar20241202 Conexión Salud con Carles Aguilar #120:00 Sintonía 1:38 Sumario 8:47 Análisis farmacogenético para personalizar tratamientos farmacológicos Hablamos de un servicio innovador de análisis farmacogenéticos que permite personalizar los tratamientos farmacológicos según el perfil genético de cada paciente. Este servicio ofrece soluciones para mejorar la eficacia y seguridad de los tratamientos, ajustando el fármaco y la dosis a las características genéticas de cada individuo y se trata de un avance significativo en la medicina de precisión, permitiendo evitar efectos adversos graves o la ineficacia de algunos medicamentos en un individuo concreto. Numerosos fármacos de uso común en atenc...2024-12-012h 13Conexión Salud con Carles AguilarConexión Salud con Carles Aguilar20241202 Conexión Salud con Carles Aguilar #12Avanzamos los contenidos de la edición número 12 de Conexión Salud hablando de un servicio innovador de análisis farmacogenéticos que permite personalizar los tratamientos farmacológicos según el perfil genético de cada paciente. Este servicio ofrece soluciones para mejorar la eficacia y seguridad de los tratamientos, ajustando el fármaco y la dosis a las características genéticas de cada individuo y se trata de un avance significativo en la medicina de precisión, permitiendo evitar efectos adversos graves o la ineficacia de algunos medicamentos en un individuo concreto. Numerosos fármacos de uso común en...2024-12-012h 13Pharma Insights 🩺Pharma Insights 🩺Content Reigns: Elevating Pharma with AI InnovationContent is King, but is AI the Queen? 👑In the life sciences industry, content creation is more challenging than ever. With the rising demands of medical and legal reviews (MLR), ensuring that every piece of content is totally precise, factually accurate, and legally compliant is a must. But how can AI help streamline these processes without adding to the complexity?In this insightful talk show, we dive into the unique challenges faced by the life sciences sector, including:🟡 Strict adherence to evolving regulations🟡 The near-zero tolerance for error🟡 The high costs associated w...2024-10-231h 00Download Best Full Audiobooks in Mystery, Thriller & Horror, HorrorDownload Best Full Audiobooks in Mystery, Thriller & Horror, Horror[Spanish] - El Maleficio de una Encarnación by Martin RehorskaPlease visit https://thebookvoice.com/podcasts/1/audiobook/810597 to listen full audiobooks. Title: [Spanish] - El Maleficio de una Encarnación Author: Martin Rehorska Narrator: Margarita Portillo Castro Format: Unabridged Audiobook Length: 2 hours 2 minutes Release date: September 13, 2024 Genres: Horror Publisher's Summary: Como parte de un proyecto de investigación médica, la Doctora Johanna Grunenthal trabaja en conectar células nerviosas humanas con la tecnología más avanzada. Un golpe del destino pone fin a su participación en el exitoso proyecto. Pronto se da cuenta de que algo anda terriblemente mal. Las visiones de pesadilla de su época de estudian...2024-09-1303 minDownload Best Full Audiobooks in Mystery, Thriller & Horror, HorrorDownload Best Full Audiobooks in Mystery, Thriller & Horror, Horror[Spanish] - El Maleficio de una Encarnación by Martin RehorskaPlease visithttps://thebookvoice.com/podcasts/1/audiobook/810597to listen full audiobooks. Title: [Spanish] - El Maleficio de una Encarnación Author: Martin Rehorska Narrator: Margarita Portillo Castro Format: Unabridged Audiobook Length: 2 hours 2 minutes Release date: September 13, 2024 Genres: Horror Publisher's Summary: Como parte de un proyecto de investigación médica, la Doctora Johanna Grunenthal trabaja en conectar células nerviosas humanas con la tecnología más avanzada. Un golpe del destino pone fin a su participación en el exitoso proyecto. Pronto se da cuenta de que algo anda terriblemente mal. Las visiones de pesadilla de su época de estudiante regresan...2024-09-132h 02Pharma Insights 🩺Pharma Insights 🩺How to Use AI to Enhance Commercial ExcellenceNavigate with us the AI landscape and choose the right tools for Commercial Excellence!In today's tech-savvy world, Artificial Intelligence and new tools are omnipresent. However, selecting the best technology is crucial to achieving your goals and empowering your team. Join us in this webinar to avoid the dazzle of tools that might not align with your objectives.In this episode, our expert panel analyzes case studies and explores successful strategies that leverage AI to enhance commercial excellence. They guide you through the best AI-driven tools tailored for achieving commercial excellence. Gain first-hand insights from...2024-06-191h 02Pharma Insights 🩺Pharma Insights 🩺Is AI The Solution to Pharma CRM Challenges?Discover the Future of #Pharma Customer Relationship Management with #ArtificialIntelligence! In this #webinar by #Platforce, we explore the transformative power of #AI in #PharmaCRM. Our panel of experts delves into a crucial industry discussion: "Is AI THE solution to Pharma CRM challenges?" 🚀 💬 Speakers and moderator 🔹 Claudia Adreani - Independent Consultant at Belly Slide Consulting 🔹 Dan Buckland - Director at Brandcast Health 🔹 Florent Edouard - SVP, Global Head of Commercial Excellence, Grünenthal Group The event is moderated by Platforce's very own Head of Marketing, Stefan Repin. Our panel of experts discussed the importance o...2024-06-021h 01MediSagas: tales in medicineMediSagas: tales in medicineMedical Reviewer Shields the U.S. from Thalidomide CatastropheThe FDA assigned newly recruited Frances Kelsey an easy case to work on. But when she found the data for the new drug application for thalidomide questionable, she refused to approve it, a delay that saved a nation from an unspeakable tragedy. *************** This episode was researched and written by Rod Tanchanco.  The voices for narration and quotes were generated by 11ElevenLabs References & Notes: Florence, A. L. (1960). Is thalidomide to blame? The British Medical Journal, 2(5217), 1954. This letter to the editor alerted Kelsey to the possible association between neuritis and thalidomide. G...2024-04-2430 minPharmaSource PodcastPharmaSource PodcastHow to ELEVATE Women in Pharma? International Women's Day Panel DebateOn International Women's Day 2024, the PharmaSource community hosted an important debate, asking "how can the biopharma industry do better at supporting and elevating women into leadership roles?" The panel included Elke Geysen, SVP Head of Global Procurement and External Supply at Grünenthal Group, Roxana Timmermans PhD, Supply Chain Procurement & Global Alliances Leader and was chaired by Alicia Ryan, Principal Consultant at Proxima. Read the full Women in Pharma article on PharmaSource2024-03-1536 minEverybody Hates PharmaEverybody Hates PharmaThe Future of Pharma: AI, CRM, and Sales – Unveiling Strategies for Success in 2024🎙️ In this podcast episode of 'Pharma Sales and Tech podcast by Platforce', our host Stefan converses with Florent, the Sales SVP of commercial excellence at Grünenthal Group.Florent shares his insights about AI's impact within the pharmaceutical industry and how it's becoming increasingly necessary for advancement. The conversation explores how Grünenthal Group uses AI in its operations and its potential role in pharmaceutical sales and marketing strategies. They also predict an 'AI winter' due to raised and often unmet expectations, and emphasize the need to invest smartly in AI. Furthermore, Florent shares a brief o...2023-12-2145 minPharma Sales & Tech Podcast by PlatforcePharma Sales & Tech Podcast by PlatforceEp.26: The Future of Pharma: AI, CRM, and Sales – Unveiling Strategies for Success in 2024Explore the future of pharmaceuticals with Florent Edouard, SVP of Commercial Excellence at Grünenthal Group.Florent discusses his role in Grünenthal, the potential of AI in the pharmaceutical industry, and the crucial role of sales and marketing. The discussion covers various aspects such as the use of AI in market research, sales strategies, and the potential for AI in creating personalized messages for doctors.Florent also shares his approach to dealing with rejection in sales and the importance of keeping the sales team motivated during tough times.Gain exclusive insights in...2023-12-2045 minBossNDataBossNDataContent Analytics With Megan ReutinContent Analytics is the practice of understanding exactly what content your organisation currently possesses, how effectively this content is being utilised and what influence this utilisation can have on your consumers or customer’s behaviour!It’s all about “reading the trails” that are left behind by people (and systems!) as content is delivered, discovered, and consumed.Megan Reutin is Global Head of Data Science & Strategy at Grunenthal Group. She’s an expert in Artificial Intelligence, social media, and Data Science. Twice Inspirational Woman of the Year finalist, she’s a bilingual thought leader who i...2023-12-1428 minWhat Your GP Doesn’t Tell YouWhat Your GP Doesn’t Tell YouThalidomide - The Story You Don’t Know (Part Two)This is the second episode of a  two parter about  a new investigation into the drug thalidomide, so if you haven’t listened to part one, please do go back and listen to that first. Thalidomide is one of the greatest medical catastrophes of the 20th century. It’s now thought to have been  responsible for around 100,000 miscarriages and disabled children. In this episode, journalist Jennifer Vanderbes reveals the second half of the story. The result of six years of research, resulting in her recent book: Wonder Drug: The Hidden Victims of America’s Secret Thalidomi...2023-11-2848 minWhat Your GP Doesn’t Tell YouWhat Your GP Doesn’t Tell YouThalidomide - The Story You Don’t Know (Part Two)This is the second episode of a  two parter about  a new investigation into the drug thalidomide, so if you haven’t listened to part one, please do go back and listen to that first. Thalidomide is one of the greatest medical catastrophes of the 20th century. It’s now thought to have been  responsible for around 100,000 miscarriages and disabled children. In this episode, journalist Jennifer Vanderbes reveals the second half of the story. The result of six years of research, resulting in her recent book: Wonder Drug: The Hidden Victims of America’s Secret Thalidomi...2023-11-2848 minCrimes of the CenturiesCrimes of the CenturiesThe Scourge of ThalidomideIn March of 1954, scientists from German pharmaceutical company Chemie Grünenthal produced Thalidomide for the first time. Thalidomide was a sedative and sleep aid sold in many countries worldwide under the name “Contergan”, as well as other brands. The medication was also being marketed and taken by pregnant women as a safe remedy for morning sickness. But in November of 1961, the drug was found to have caused severe deformities in newborn children if taken during a specific point in the pregnancy. In today's episode, we learn more about what led to the Thalidomide scandal and the outcomes from the worst drug...2023-11-2038 minDigital Transformation SeriesDigital Transformation SeriesMehrnaz Campbell in conversation with Florent Edouard, SVP - Global Head of Commercial Excellence, GrünenthalAs part of my DIGITAL TRANSFORMATION SERIES, I thoroughly enjoyed talking to Florent Edouard about his diverse career and opinions on various industry topics! We related on so many topics and you can hear so many nuggets of golden information from him! A few of Florent’s points: To create a culture of innovation organisations need to stop micromanaging their teams. They need to let them learn along the way and make mistakes! The pharmaceutical sales representative’s role should be the orchestrator of the omnichannel and customer experience. Represe...2023-11-1529 minHR Visionaries DeutschlandHR Visionaries DeutschlandGrünenthal | Eine Welt ohne SchmerzenIn der heutigen Podcast-Folge sprechen wir mit Anne und Oliver von Grünenthal, einem forschenden Pharmaunternehmen. Sie geben spannende Einblicke in die verschiedenen Funktionsbereiche im Unternehmen - von der frühen Forschung bis hin zur Kommerzialisierung der Produkte. Außerdem sprechen sie von der Arbeit im Familienunternehmen, inwiefern der Purpose eine Rolle spielt und von der Internationalität an den verschiedenen Standorten. Wir freuen uns über das aufschlussreiche Gespräch! Mehr zu Anne, Oliver und Grünenthal: https://www.linkedin.com/in/anne-severich-265852191/ https://www.linkedin.com/in/oliver-lamm-bb8754a0/ https://www.linkedin.com/com...2023-10-1148 minRebélate contra el dolorRebélate contra el dolorDolor crónico en EspañaEn España, el dolor crónico afecta a una considerable proporción de la población adulta, con un 25,9% de afectados, lo que representa más de 9 millones de personas, según el Barómetro del dolor crónico en España, realizado por la Fundacion Grunenthal y el Observatorio del Dolor de la Universidad de Cádiz. Estos datos, que fueron compartidos por el Dr. Trinidad en el programa "Rebélate contra el dolor" de Onda Cero Cádiz, revelan una problemática relevante en nuestra sociedad. La prevalencia del dolor crónico varía según la edad y el género...2023-09-1309 minDMPK InsightsDMPK InsightsDMPK Insights #1: Candidate Survival – 3 Pillars to 5Rs and BeyondIn this podcast, Dr. Paul Morgan, Head of DMPK at Grünenthal Group, discusses the development of the publication that introduced the “5R framework” and improved the likelihood of AstraZeneca candidate survival from candidate drug nomination to Phase III. We will then discuss how the area has developed since then and where the field may go in the future.The episode addresses the following questions:What was the situation like that led to the development of the 5Rs?How was the analysis conducted?How was this analysis accepted both within the organization and externally?What changes occur...2023-09-1245 minAlgoritmo SaludAlgoritmo Salud¿Dónde buscan los médicos en internet?Datos del primer estudio “Medic@ Digital en México 2022 de FUNSALUD” menciona que los profesionales de la salud utilizan diariamente sitios web para su práctica médica ya sea para buscar nuevas investigaciones, tratamientos emergentes y herramientas tecnológicas: estas fuentes les permiten mantenerse al día con los últimos avances y ofrecer a sus pacientes tratamientos más innovadores. Hoy, el profesional de la salud y el paciente pueden encontrar en línea un gran abanico de información, pero en ambos casos, deben ser muy cuidadosos en evaluar las fuentes consultadas y evitar caer en sitios p...2023-09-0850 minHealthcare Changers PodcastHealthcare Changers Podcast#40: Karl Wögenstein, Grünenthal [>] Führen CEOs mit Medical Background anders?Mit seiner Ausbildung in Molekularbiologie hat Karl Wögenstein, derzeitiger Geschäftsführer von Grünenthal Österreich, einen einzigartigen Blick auf die Herangehensweise und Kollaboration der Pharmaindustrie. In dieser Episode spricht er mit René Neubach und Dominik Flener über diese Ansätze sowie die Vision des Unternehmens "the world free of pain".Dabei diskutiert Karl Wögenstein auch das Thema Omni-Channel und erklärt den Status von Grünenthal Österreich sowie die Maßnahmen, die das Unternhemen dabei ergreift. Er erklärt außerdem die Position, die Grünenthal gegenüber Stakeholdern und als Arbeitgeber einnimmt. Dabei geht er auch auf...2023-08-091h 08Das ThemaDas ThemaContergan: Der Skandal geht weiter Der deutsche Pharmakonzern Grünenthal aus Stolberg brachte 1957 das Mittel Contergan auf den Markt. Ein Schlafmittel, rezeptfrei, frei verkäuflich in der Apotheke, das weltweit als harmlos und "völlig ungiftig" beworben wird. Da es auch gegen Schwangerschaftsübelkeit wirken soll, nehmen es auch Tausende Schwangere. Mit fatalen Folgen: Denn der in Contergan enthaltene Wirkstoff Thalidomid führt zu Nervenschädigungen - und schweren embryonalen Störungen. Allein in Deutschland werden etwa 5000 Babys mit missgebildeten Organen und Gliedmaßen geboren. Etwa 40 Prozent der Kinder sterben sehr schnell nach der Geburt oder noch im Säuglingsalter. Anklage gegen Grünentha...2023-07-1932 minPharmaSource PodcastPharmaSource PodcastSpeed is Greater than Savings - How Grünenthal Created a Procurement Centre of Excellence Focused on Speed Dr. Thortsen Fallisch, Head of Global R&D Procurement at Grünenthal spoke to PharmaSource about his experience in setting up a Procurement Centre of Excellence and why speed can be more important than savings. Thorsten joined Grünenthal at an exciting time when it centralised Procurement was a  "new, mostly unshaped  function". It meant he could make a real impact on the function and see the improving results. Establishing a Sourcing Board One of the first areas they identified was that there was not  a standardised process for the category managers to do so...2023-06-1441 minRadiogramasRadiogramasRadiogramas - Talidomida - 03/04/23El pasado 21 de marzo de 2023, el día de la frustrada moción de censura presentada por Vox y defendida por Ramón Tamames, los miembros de Avite, la asociación española de afectados por la talidomida, protagonizaron una protesta frente al Congreso de los Diputados. Llegaron en sus sillas de ruedas, con sus piernas ortopédicas, con sus brazos cortos y sus manos pegadas a los hombros, una vez más, para reclamar justicia, indemnizaciones y con la esperanza de ser escuchados. ...2023-04-0357 minSECOTSECOTGrúnenthalLa 'columna vertebral' de Grünenthal Pharma es el dolor, pero... ¿Qué relación tiene esta compañía con la traumatología? ¿Y de qué forma colabora con la SECOT? Para hablar de esto y muchos asuntos más contamos con Álex González, Director de Ventas de Grünenthal.2023-02-2326 minGROW UP TALENTOGROW UP TALENTO🤘Aprendiendo de los mejores_ Resumen de 1 año de ¡GROW UP TALENTO!“Gracias por un año de aprendizaje” Finalizado el 2022, vamos a compartir lo aprendido. Mayte Tortosa y Daniel Becerra Ortega repasan los programas sobre talento, desarrollo y aprendizaje para Seguir 🤘Aprendiendo de los mejores. | Resumen de 1 año de ¡GROW UP TALENTO!. #talento #aprendizaje #desarrolloprofesional  El aprendizaje no es solo cuestión de hacer y de experiencia. El verdadero aprendizaje está en reflexionar sobre la experiencia. Cuando reflexionas sobre la experiencia, es cuando desechas lo ineficiente, conservas lo útil y sabes cuáles son los nuevos horizontes. Por eso, cerram...2023-01-261h 02La Minute RhumatoLa Minute RhumatoRhumatisme psoriasique axial : mythe ou réalité ?Qu’est-ce que le rhumatisme psoriasique axial ? Le rhumatisme psoriasique axial existe-t-il vraiment ? Quel est l’impact pour la pratique en rhumatologie ? Quel message passer aux auditeurs ? Le Pr Daniel Wendling, rhumatologue dans le service de rhumatologie au CHU de Besançon, répond à vos questions.   Invité : Pr Daniel Wendling – CHU de Besançon https://www.chu-besancon.fr/offre-de-soins/les-services-et-activites/rhumatologie.html  Le Pr Wendling déclare des liens d'intérêts avec les laboratoires AbbVie, BMS, MSD, Pfizer, Roche Chugai, Amgen, Nordic Pharma, UCB, Novartis, Janssen, Lilly, Sandoz, Grunenthal, Galapagos, Mylan, Fres...2023-01-1905 minRisk & Compliance ItaliaRisk & Compliance ItaliaMichela Barbarossa - ESG, obiettivo sostenibilità e la direttiva CSRDL’ospite del nostro podcast di oggi è Michela BARBAROSSA. L’avvocato BARBAROSSA è Head of Legal & Compliance IT e, da poco, Board member di Grünenthal Italia (ed anche autrice – con grande seguito – per la Piattaforma di Risk & Compliance).Il tema ESG (Environmental, Social, Governance) porta con sé molto fermento: in tutte le aziende, dal Cda fino alle riunioni fra colleghi ma anche nelle istituzioni e, fra amici. È una nuova sfida; ed è noto che, a livello di organizzazione, il primo ambito coinvolto sia l’Ufficio Legale.Parliamo con Michela BARBAROSSA di come l’Ufficio Legale...2023-01-1420 minVia OralVia OralRenê Delsin o Maestro da GrünenthalQue tal enviar uma mensagem ;-)Que tal conhecer a alemã de 76 anos e 10 no Brasil focada na dor, essa é a missão atual da Grünenthal que tem como seu principal líder o Renê Delsin. Conversamos com ele sobre música, incertezas, trabalho híbrido e os atributos principais do colaborador moderno.Renê indica o livro Redefining Health Care.Todos os dias 5 e 20 do mês!Obrigado por ouvir, acesse @viaoral ou nosso site viaoral.com.br2022-10-2036 minSince the World\'s been TurningSince the World's been TurningEpisode 64 - Children of ThalidomideIn this episode we’re looking at what is arguably the greatest medical catastrophe in recent history, the Thalidomide Scandal. A drug designed to reduce morning sickness in pregnant women, Thalidomide caused more than 10,000 children in the late 1950s and early 1960s to be born with intense physical disabilities. Pushed primarily under the name Contergan by German company Chemie Grunenthal, the history of Thalidomide is one of corporate greed, negligible accountability, and minimal consequences. To help us explore this complex and difficult subject, we have two guests. The first, James Essinger, author of “Frankie: The Woman Who Saved...2022-09-1644 minChemistry ConnectionsChemistry ConnectionsChemistry of ThalidomideHopewell Valley Student Podcasting NetworkChemistry ConnectionsPharmaceutical ChemistryEpisode #7  Welcome to Chemistry Connections, my name is Eve O’Leary and I am your host for Episode 7 called Pharmaceutical Chemistry. Today I will be discussing The Thalidomide Tragedy.Segment 1: Introduction to The Thalidomide TragedyDeveloped in Germany in the 1950s, thalidomide is a sedative drug that was administered to pregnant women experiencing morning sickness and insomnia associated with pregnancy. After its five years spent on the market, it was later discovered that the medicine was the cause for...2022-07-0108 minUni2 talksUni2 talksLa Medicina Rural del S. XXIEntrevista con el Dr. Carlos Moral Paredes, Médico de Familia CS. de Chandrexa de Queixa y Jefe del Servicio de Atención Primaria de Castro Caldelas (Ourense), en la que repasaremos como es el día a día de un médico rural, las ventajas y desventajas de este entorno, y como ve el ejercicio de su profesión en el futuro2022-06-0813 minLa Minute RhumatoLa Minute RhumatoLe régime dans la goutte : pourquoi et comment ?Quel rôle joue l’alimentation dans l’augmentation de l’uricémie ? Existe-t-il des régimes qui diminuent l’uricémie ? La perte de poids améliore-t-elle les patients souffrant de goutte ? Faut-il modifier l’alimentation des patients atteints de goutte ?   Le Pr Pascal Richette, rhumatologue, PU-PH et chef de service de Rhumatologie de l’hôpital Lariboisière à Paris, répond à vos questions.   Invité : Pr Pascal Richette – Hôpital Lariboisière – Paris https://www.aphp.fr/service/service-01-047  Le Pr Richette déclare les liens d'intérêts suivants : Grunenthal. ...2022-05-1905 minVentaja LegalVentaja LegalVentaja Legal: malas noticias para los afectados por la TalidomidaEs el caso más injusto con pacientes que han sufrido los efectos adversos de un fármaco en España: La talidomida. Recordemos que si bien el TS estableció que la empresa Grünenthal, fue la responsable de las malformaciones de aquellos bebés hoy adultos, también declaró que la acción para exigir su responsabilidad había prescrito.2022-03-2301 minVentaja LegalVentaja LegalVentaja Legal: malas noticias para los afectados por la TalidomidaEs el caso más injusto con pacientes que han sufrido los efectos adversos de un fármaco en España: La talidomida. Recordemos que si bien el TS estableció que la empresa Grünenthal, fue la responsable de las malformaciones de aquellos bebés hoy adultos, también declaró que la acción para exigir su responsabilidad había prescrito.2022-03-2301 minVentaja LegalVentaja LegalVentaja Legal: malas noticias para los afectados por la TalidomidaEs el caso más injusto con pacientes que han sufrido los efectos adversos de un fármaco en España: La talidomida. Recordemos que si bien el TS estableció que la empresa Grünenthal, fue la responsable de las malformaciones de aquellos bebés hoy adultos, también declaró que la acción para exigir su responsabilidad había prescrito.2022-03-2301 min